Advertisement
Screener

Diebold Nixdorf, Incorporated (DBD) Spending and interest coverage

Diebold Nixdorf, Incorporated (DBD) Spending and interest coverage

  • R&D / revenue · 12 months: Value 2.17%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 0.34%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months2.17%Research and development expense / revenue. Period ending 2026-06-30.

$84.20M ÷ $3.87B × 100 ≈ 2.17%

Stock-based compensation / revenue · 12 months0.34%Share-based compensation / revenue. Period ending 2026-06-30.

$13.20M ÷ $3.87B × 100 ≈ 0.34%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending84.20M USDResearch and Development Expense
Revenue3.87B USD
Stock-based compensation13.20M USDShare-based Payment Arrangement, Noncash Expense
Operating income246.20M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$84.20M$3.87B$13.20M$246.20M(m)2.17%0.34%(m)(m)
2026-03-31$86.10M$3.86B$12.30M$245.10M(m)2.23%0.32%(m)(m)
2025-12-31$86.70M$3.81B$12.10M$242.00M(m)2.28%0.32%(m)(m)
2025-09-30$89.20M$3.69B$11.60M$200.80M(m)2.42%0.31%(m)(m)
2025-06-30$92.40M$3.67B$11.50M$173.40M(m)2.52%0.31%(m)(m)
2025-03-31$92.10M$3.70B$10.80M$187.90M(m)2.49%0.29%(m)(m)
2024-12-31$93.60M$3.75B$9.70M$182.10M(m)2.50%0.26%(m)(m)
2024-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-08-12(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-08-11(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-06-30$107.10M$3.56B$8.60M$-42.80M$253.10M3.01%0.24%-0.17×Reported
2023-03-31$114.80M$3.49B$13.00M$-130.40M$233.00M3.29%0.37%-0.56×Reported
2022-12-31$120.70M$3.46B$13.40M$-211.70M$199.20M3.49%0.39%-1.06×Reported
2022-09-30$123.10M$3.55B$10.70M$-120.10M$194.00M3.47%0.30%-0.62×Reported
2022-06-30$122.00M$3.70B$12.70M$-86.90M$194.60M3.30%0.34%-0.45×Reported
2022-03-31$124.50M$3.79B$12.00M$17.50M$194.70M3.28%0.32%0.09×Reported
2021-12-31$126.30M$3.91B$13.80M$137.10M$195.30M3.23%0.35%0.70×Reported
2021-09-30$135.30M$3.95B$16.50M$93.50M$201.80M3.42%0.42%0.46×Reported
2021-06-30$139.90M$3.99B$15.30M$78.60M$294.80M3.51%0.38%0.27×Reported
2021-03-31$135.00M$3.94B$14.40M$86.20M$293.40M3.43%0.37%0.29×Reported
2020-12-31$133.40M$3.90B$14.90M$24.00M$292.70M3.42%0.38%0.08×Reported
2020-09-30$130.70M$3.95B$15.70M$-14.30M$290.20M3.31%0.40%-0.05×Reported
2020-06-30$137.30M$4.03B$17.50M$-14.90M$198.40M3.41%0.43%-0.08×Reported
2020-03-31$142.70M$4.29B$18.70M$-28.10M$200.00M3.33%0.44%-0.14×Reported
2019-12-31$147.10M$4.41B$24.00M$-26.60M$202.90M3.34%0.54%-0.13×Reported
2019-09-30$148.30M$4.55B$28.80M$-46.50M$208.60M3.26%0.63%-0.22×Reported
2019-06-30$148.10M$4.59B$30.40M$-230.00M$201.30M3.23%0.66%-1.14×Reported
2019-03-31$152.60M$4.54B$32.20M$-363.90M$179.80M3.36%0.71%-2.02×Reported
2018-12-31$157.40M$4.58B$36.60M$-362.90M$154.90M3.44%0.80%-2.34×Reported
2018-09-30$160.00M$4.54B$38.00M$-281.90M$126.20M3.53%0.84%-2.23×Reported
2018-06-30$157.60M$4.54B$39.20M$-157.40M$108.70M3.47%0.86%-1.45×Reported
2018-03-31$155.80M$4.57B$40.80M$-56.00M$112.50M3.41%0.89%-0.50×Reported
2017-12-31$155.50M$4.61B$33.90M$-83.60M$117.30M3.37%0.74%-0.71×Reported
2017-09-30$157.20M$4.60B$31.10M$-164.00M$123.90M3.42%0.68%-1.32×Reported
2017-06-30$154.30M$4.46B$27.10M$-243.10M$128.60M3.46%0.61%-1.89×Reported
2017-03-31$133.10M$3.91B$23.40M$-202.70M$120.70M3.40%0.60%-1.68×Reported
2016-12-31$110.20M$3.32B$22.20M$-159.80M$101.40M3.32%0.67%-1.58×Reported
2016-09-30$88.10M$2.68B$15.70M$-56.90M$76.60M3.28%0.59%-0.74×Reported
2016-06-30$76.80M$2.29B$13.40M$42.20M$52.70M3.35%0.59%0.80×Reported
2016-03-31$83.10M$2.35B$13.70M$55.90M$36.00M3.53%0.58%1.55×Reported
2015-12-31$86.90M$2.42B$12.40M$58.60M$32.50M3.59%0.51%1.80×Reported
2015-09-30$93.62M$2.93B$16.45M$107.65M$32.42M3.19%0.56%3.32×Reported
2015-06-30$98.12M$3.02B$20.25M$134.75M$32.22M3.25%0.67%4.18×Reported
2015-03-31$95.92M$3.02B$20.84M$161.25M$32.52M3.18%0.69%4.96×Reported
2014-12-31$93.62M$3.05B$21.55M$180.95M$31.42M3.07%0.71%5.76×Reported
2014-09-30$92.08M(m)$17.34M$76.73M$30.35M(m)(m)2.53×Reported
2014-06-30$89.58M$2.94B$15.34M$-241.00K$29.88M3.05%0.52%-0.01×Reported
2014-03-31$91.36M$2.91B$13.33M$-81.06M$28.81M3.14%0.46%-2.81×Reported
2013-12-31$92.31M$2.86B$15.43M$-118.26M$29.23M3.23%0.54%-4.05×Reported
2013-09-30$91.14M(m)$18.05M$-55.38M$29.67M(m)(m)-1.87×Reported
2013-06-30$91.36M$2.89B$18.61M$-4.10M$29.37M3.16%0.64%-0.14×Reported
2013-03-31$88.11M$2.93B$17.23M$56.15M$30.07M3.01%0.59%1.87×Reported
2012-12-31$85.88M$2.99B$13.84M$124.71M$30.33M2.87%0.46%4.11×Reported
2012-09-30$81.98M$3.00B$13.65M$184.41M$30.84M2.73%0.45%5.98×Reported
2012-06-30$78.28M$3.00B$13.38M$216.16M$31.34M2.61%0.45%6.90×Reported
2012-03-31$77.48M$2.92B$14.66M$201.37M$33.39M2.65%0.50%6.03×Reported
2011-12-31$78.11M$2.84B$14.30M$155.59M$34.46M2.75%0.50%4.52×Reported
2011-09-30$77.55M$2.78B$13.62M$-53.24M$36.20M2.79%0.49%-1.47×Reported
2011-06-30$78.17M$2.82B$12.79M$-55.27M$37.72M2.78%0.45%-1.47×Reported
2011-03-31$75.20M$2.82B$12.75M$-33.52M$37.51M2.67%0.45%-0.89×Reported
2010-12-31$74.22M$2.82B$12.54M$-1.80M$37.89M2.63%0.44%-0.05×Reported
2010-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-12-31$72.03M$2.72B$11.91M$150.59M$35.45M2.65%0.44%4.25×Reported
2009-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2008-12-31$73.03M$3.08B$12.19M$182.91M$45.37M2.37%0.40%4.03×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
NCR Voyix Corp (VYX)United States$0.979B14.79
NCR Atleos Corp (NATL)United States$3.394B16.18
PAR TECHNOLOGY CORP (PAR)United States$0.577B-10.00